Kendall Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kendall Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$252
+1.2%
2,4700.0%0.11%
+2.8%
Q2 2023$249
-2.4%
2,470
-10.8%
0.11%
-11.4%
Q1 2023$2550.0%2,770
-1.6%
0.12%
-4.7%
Q4 2022$255
-99.9%
2,816
-10.3%
0.13%
-7.2%
Q3 2022$239,000
-14.0%
3,141
-4.6%
0.14%
-9.2%
Q2 2022$278,000
-7.3%
3,293
-3.7%
0.15%
+5.5%
Q1 2022$300,000
+0.3%
3,4180.0%0.14%
+2.1%
Q4 2021$299,000
+6.8%
3,418
-0.3%
0.14%
-6.0%
Q3 2021$280,000
-10.3%
3,427
+0.3%
0.15%
-13.7%
Q2 2021$312,000
+3.7%
3,418
-2.8%
0.18%
-5.9%
Q1 2021$301,000
-9.3%
3,5180.0%0.19%
-23.1%
Q4 2020$332,000
+13.7%
3,518
+4.8%
0.24%
-4.7%
Q3 2020$292,000
-16.1%
3,358
-15.7%
0.25%
-23.7%
Q2 2020$348,000
+6.4%
3,983
+0.4%
0.33%
-10.0%
Q1 2020$327,000
-13.7%
3,968
-0.9%
0.37%
+24.2%
Q4 2019$379,000
+6.8%
4,005
-1.8%
0.30%
-5.1%
Q3 2019$355,000
-5.8%
4,080
-1.2%
0.31%
-7.9%
Q2 2019$377,000
-8.9%
4,130
-4.2%
0.34%
-13.0%
Q1 2019$414,000
+8.1%
4,310
-3.4%
0.39%
-1.3%
Q4 2018$383,000
-6.6%
4,460
-6.3%
0.40%
+13.8%
Q3 2018$410,000
-25.2%
4,760
-34.4%
0.35%
-27.9%
Q2 2018$548,000
-8.8%
7,260
-2.4%
0.48%
-7.1%
Q1 2018$601,000
+25.7%
7,435
+30.7%
0.52%
+22.9%
Q4 2017$478,0005,6900.42%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders